HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Estee Lauder Companies: Coronavirus Will Drag On Growth Engines In FY 2020 Back Half

Executive Summary

The Estee Lauder Companies has lowered its full-year guidance to account for store closures, canceled travel plans and other effects of the coronavirus outbreak. The firm achieved record-setting 16% organic growth in the second quarter, led by China, travel retail and skin care, and is confident that it can get quickly back to speed once markets recover from the global health scare.

You may also be interested in...



For Estee Lauder Companies, COVID-19 Has Changed Everything And Nothing

Lauder’s business has been thrashed by COVID-19, but the firm is encouraged that its biggest growth drivers before the crisis are the same ones carrying it through.

What A Difference A Quarter Can Make: Estee Lauder Companies’ Q3 Results

From record organic growth to a 9% decline, The Estee Lauder Companies’ fiscal performance over the past two quarters illustrates sharply the devastating and largely unanticipated impact of the COVID-19 pandemic, even for firms best-positioned to ride it out.

PCPC Leads Off Annual Meeting With Coronavirus Remarks: “A Significant New World Overnight”

Coronavirus was a factor in attendance of the Personal Care Products Council’s 2020 annual meeting in Palm Beach, FL. Opening the conference on 2 March, chairman George Calvert, chief supply chain officer at Amway, discussed with CEO Lezlee Westine the epidemic’s ongoing impact on supply networks and global cosmetics business.

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel